Advances in structure-based drug discovery of carbonic anhydrase inhibitors.
about
Comparison of the Sulfonamide Inhibition Profiles of the β- and γ-Carbonic Anhydrases from the Pathogenic Bacterium Burkholderia pseudomallei.Sequence Analysis, Kinetic Constants, and Anion Inhibition Profile of the Nacrein-Like Protein (CgiNAP2X1) from the Pacific Oyster Magallana gigas (Ex-Crassostrea gigas).N-Acylbenzenesulfonamide Dihydro-1,3,4-oxadiazole Hybrids: Seeking Selectivity toward Carbonic Anhydrase Isoforms.Novel Sulfamide-Containing Compounds as Selective Carbonic Anhydrase I Inhibitors.Genome-wide loss-of-function genetic screening identifies opioid receptor μ1 as a key regulator of L-asparaginase resistance in pediatric acute lymphoblastic leukemiaCarbonic Anhydrase from Porphyromonas Gingivalis as a Drug Target.Carbonic Anhydrase Inhibition and the Management of Hypoxic Tumors.Production and covalent immobilisation of the recombinant bacterial carbonic anhydrase (SspCA) onto magnetic nanoparticles.A one-step procedure for immobilising the thermostable carbonic anhydrase (SspCA) on the surface membrane of Escherichia coli.Biochemical characterization of the native α-carbonic anhydrase purified from the mantle of the Mediterranean mussel, Mytilus galloprovincialis.An update on anticancer drug development and delivery targeting carbonic anhydrase IX.An Overview of the Bacterial Carbonic Anhydrases.Discovery of curcumin inspired sulfonamide derivatives as a new class of carbonic anhydrase isoforms I, II, IX, and XII inhibitors.Dual targeting of cancer-related human matrix metalloproteinases and carbonic anhydrases by chiral N-(biarylsulfonyl)-phosphonic acids.Psychoactive substances belonging to the amphetamine class potently activate brain carbonic anhydrase isoforms VA, VB, VII, and XII.Quantitative assessment of specific carbonic anhydrase inhibitors effect on hypoxic cells using electrical impedance assays.Synthesis and biological evaluation of histamine Schiff bases as carbonic anhydrase I, II, IV, VII, and IX activators.Synthesis and carbonic anhydrase I, II, VII, and IX inhibition studies with a series of benzo[d]thiazole-5- and 6-sulfonamides.Cloning, expression and purification of the α-carbonic anhydrase from the mantle of the Mediterranean mussel, Mytilus galloprovincialis.Novel 6- and 7-Substituted Coumarins with Inhibitory Action against Lipoxygenase and Tumor-Associated Carbonic Anhydrase IX.Special Issue: Sulfonamides.Activation Profile Analysis of CruCA4, an α-Carbonic Anhydrase Involved in Skeleton Formation of the Mediterranean Red Coral, Corallium rubrum.Potent and Selective Carboxylic Acid Inhibitors of Tumor-Associated Carbonic Anhydrases IX and XII.Rethinking the Combination of Proton Exchanger Inhibitors in Cancer Therapy.Benzoxaboroles as Efficient Inhibitors of the β-Carbonic Anhydrases from Pathogenic Fungi: Activity and Modeling Study.Activation studies of the α- and β-carbonic anhydrases from the pathogenic bacterium Vibrio cholerae with amines and amino acids.Activation studies with amines and amino acids of the β-carbonic anhydrase encoded by the Rv3273 gene from the pathogenic bacterium Mycobacterium tuberculosis.Carbonic anhydrase I, II, IV and IX inhibition with a series of 7-amino-3,4-dihydroquinolin-2(1H)-one derivatives.Synthesis of an acridine orange sulfonamide derivative with potent carbonic anhydrase IX inhibitory action.Exploiting the Ref-1-APE1 node in cancer signaling and other diseases: from bench to clinic.Carbonic Anhydrases and Metabolism.The first activation study of a δ-carbonic anhydrase: TweCAδ from the diatom Thalassiosira weissflogii is effectively activated by amines and amino acids.Crystal structure correlations with the intrinsic thermodynamics of human carbonic anhydrase inhibitor binding.Inhibition studies of Brucella suis β-carbonic anhydrases with a series of 4-substituted pyridine-3-sulphonamides.Sulphonamide inhibition studies of the β-carbonic anhydrase from the bacterial pathogen Clostridium perfringens.Comparison of the amine/amino acid activation profiles of the β- and γ-carbonic anhydrases from the pathogenic bacterium Burkholderia pseudomallei.Dioxygen, an unexpected carbonic anhydrase ligand.Discovery of novel 1,3-diaryltriazene sulfonamides as carbonic anhydrase I, II, VII, and IX inhibitorsFamotidine, an Antiulcer Agent, Strongly Inhibits and Human Carbonic AnhydrasesAssessment of the antiproliferative and apoptotic roles of sulfonamide carbonic anhydrase IX inhibitors in HeLa cancer cell line
P2860
Q36300465-E2458CA5-738E-4F57-BBE1-B9C1FB495BF4Q38605750-BFEB4E79-A610-4130-A15C-5BF9A6A6F531Q38611056-32102525-B6C9-4580-9D8F-9285C18EE57CQ38696021-B45A8438-509F-4ECF-90F6-6C178D8A643EQ38709044-2AA0B4CC-6FAF-424D-9CF7-5D0E648ABABFQ39438781-48D7A33C-0CB3-4AE6-B143-0F1AA38D1C98Q41666673-1A7EF89A-11CB-46D6-BE41-C9A19055E4A2Q43030626-22E7BCE2-6757-4719-B5CD-2A39A5C63C7AQ43031787-C61CE3D8-CE4C-4E26-A86A-DDBEEA52C49FQ46275610-EB81D8C8-1EFC-465E-84E4-FD3B099C2E7AQ47096060-66799710-F0EC-4703-8059-2F5155B6D07AQ47145746-0A1FC736-0217-4441-8B54-4FFE3BB1D668Q47719833-E76B427E-7BD7-4D4D-913E-F76BC8EA5944Q47742715-DEBE9B29-6A18-43FA-B462-C702D5110CB7Q47763146-C51AA38D-307A-4E76-B60A-55B2847A1939Q47809412-A9C32376-2AE6-42FC-B503-AEBEA427D028Q48000247-8545DEFB-BCD8-45ED-848C-91134CDA8D0EQ48017394-EEFFDD30-4973-4A95-A146-7B32390DD946Q48031363-06C56B75-4EEF-416F-9086-7C3BC329243EQ48253361-5F2066AE-8844-413A-BAB9-00871BCE3BC9Q48268820-EC7AF582-EF7A-418F-865F-ECBCF6617177Q48337520-EEA4D264-5DEC-42DD-87CD-6A10838F1AFBQ48356771-A4F2B0F7-E447-4E71-A057-7AE30326C4FAQ48552373-F02DAF2F-2C77-420B-A1F1-2CB489843213Q49897501-63EC9561-AE36-45A1-A14D-4398118DC764Q49901647-84F28B83-274E-400F-B0B0-86504C4F7282Q50095685-D612CFBC-3517-4360-ABB9-FA977880ED3EQ50927587-56C2346E-D5B9-4FE0-8166-35FC549A669CQ51089283-E6AD5C3F-CE99-44B2-B3A5-C9B9C505D1EEQ51825149-3630AEF1-CBC9-4B39-BB46-824CCDFD279DQ52645009-7545EE07-8C67-41D7-9248-089AE72908FFQ52656627-10EF53CD-5EB5-4318-A0F1-5C9F5AFA7EB4Q52674801-CF0157A7-901B-42B1-AA97-615F226A3375Q52739206-F6B6B21D-9ECE-4404-9BA4-199CA33D05CBQ52816899-D7061604-D04E-45CE-BDEC-973C3DD31ED9Q52816943-7AA52E30-DFC0-4853-A219-D9CC922BD6AFQ55526704-EF1C4BF0-51F5-4192-8A3F-125252AFD3C9Q57279715-AC14A282-DDEE-4D87-9C51-8CA55C5F1D0CQ57822498-36D214EA-AECF-457B-AAB2-86AD9838181CQ58539473-F04D1466-5990-422F-969B-91CFE039FF91
P2860
Advances in structure-based drug discovery of carbonic anhydrase inhibitors.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Advances in structure-based drug discovery of carbonic anhydrase inhibitors.
@en
type
label
Advances in structure-based drug discovery of carbonic anhydrase inhibitors.
@en
prefLabel
Advances in structure-based drug discovery of carbonic anhydrase inhibitors.
@en
P2860
P1476
Advances in structure-based drug discovery of carbonic anhydrase inhibitors.
@en
P2093
Claudiu T Supuran
P2860
P356
10.1080/17460441.2017.1253677
P407
P577
2016-10-26T00:00:00Z